Topical glucocorticosteroids in rhinitis: Clinical aspects

Acta Oto-Laryngologica

Volumn 126, Issue 10, 2006, Pages 1022-1029

  Mygind, Niels ^a   Andersson, Morgan ^b  

^a LILLEBAELT HOSPITAL   (Denmark)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BECLOMETASONE DIPROPIONATE; BUDESONIDE; CROMOGLYCATE DISODIUM; DEXAMETHASONE; FLUNISOLIDE; FLUTICASONE PROPIONATE; GLUCOCORTICOID; LORATADINE; MACROGOL; MOMETASONE FUROATE; MONTELUKAST; NOSE SPRAY; PLACEBO; PROPYLENE GLYCOL; TRIAMCINOLONE ACETONIDE; WATER;

ALLERGIC RHINITIS; CLINICAL TRIAL; COMMON COLD; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; DRY NOSE; EPISTAXIS; GROWTH INHIBITION; HAY FEVER; HUMAN; NOSE MUCOSA; NOSE POLYP; NOSE SEPTUM PERFORATION; PEDIATRICS; PREGNANCY; PRIORITY JOURNAL; REVIEW; RHINITIS; RHINITIS MEDICAMENTOSA; SIDE EFFECT; SINUSITIS; SNEEZING;

ADMINISTRATION, TOPICAL; ANDROSTADIENES; ANIMALS; BECLOMETHASONE; BUDESONIDE; DEXAMETHASONE; EOSINOPHILS; FLUOCINOLONE ACETONIDE; GLUCOCORTICOIDS; HUMANS; NASAL MUCOSA; NASAL POLYPS; PREGNADIENEDIOLS; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RHINITIS; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE;

EID: 33747686156     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480600672550     Document Type: Review

References (96)

1. Mygind N. Local effect of intranasal beclomethasone dipropionate aerosol in hay fever. Br Med J 1973;4:464-6.
2. Brogden RN, Heel RC, Speight TM, Avery GS. Beclomethasone dipropionate. A reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis. Drugs 1984;28:99-126.
3. Clissold SP. Rhinitis. In: Barnes PJ, Mygind N, editors. Budesonide: clinical experience in asthma and rhinitis. Manchester: ADIS Press; 1988. p. 51-64.
4. Naclerio RM, Mygind N. Intranasal steroids. In: Mygind N, Naclerio RM, editors. Allergic and non-allergic rhinitis: clinical aspects. Copenhagen: Munksgaard; 1993. p. 114-22.
5. Pakes GE, Brogden RN, Heel RD, Speight TM, Avery GS. Flunisolide: a review of its pharmacological properties and therapeutic efficacy in rhinitis. Drugs 1980;19:397-411.
6. Siegel SC. Topical intranasal corticosteroid therapy in rhinitis. J Allergy Clin Immunol 1988;81:984-91.
7. Lund VJ. International consensus report on the diagnosis and management of rhinitis. Allergy 1994;49(Suppl 19):1-34.
8. van Cauwenberge P, Bachert C, Passalacqua G, Bousquet J, Canonica GW, Durham SR, et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 2000;55:116-34.
9. Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108:S147-S334.
10. Norman PS, Winkenwerder WL, Agbayani BF, Migeon CJ. Adrenal function during the use of dexamethasone aerosols in the treatment of ragweed hay fever. J Allergy Clin Immunol 1967;40:57-61.
11. Turkeltaub PC, Norman PS, Crepea S. Treatment of ragweed hay fever with an intranasal spray containing flunisolide: a new synthetic corticosteroid. J Allergy Clin Immunol 1976;58:597-606.
12. Balle VH, Pedersen U, Engby B. Allergic perennial and nonallergic vasomotor rhinitis treated with budesonide nasal spray. Rhinology 1980;18:135-42.
13. Harding SM. The human pharmacology of fluticasone propionate. Respir Med 1990;84(Suppl A):25-9.
14. Scadding GK, Lund VJ, Holmstrom M, Darby YC. Clinical and physiological effects of fluticasone propionate aqueous nasal spray in the treatment of perennial rhinitis. Rhinology 1991;(Suppl 11):37-43.
15. Dolovich J, Wong AG, Chodirker WB, Drouin MA, Hargreave FE, Hebert J, et al. Multicenter trial of fluticasone propionate aqueous nasal spray in ragweed allergic rhinitis. Ann Allergy 1994;72:147-53.
16. Findley S, Huber F, Garcia J, Huang L. Efficacy of once-a-day intranasal administration of triamcinolone acetonide in patients with seasonal allergic rhinitis. Ann Allergy 1992;68:228-32.
17. Onrust SV, Lamb HM. Momethasone furoate. A review of its intranasal use in allergic rhinitis. Drugs 1998;56:725-45.
18. Ratner PH, Paull BR, Findlay SR, Hampel F Jr, Martin B, Kral KM, Rogenes PR. Fluticasone proprionate given once daily is as effective for seasonal allergiz rhinitis as beclomethasone dipropionate given twice daily. J Allergy Clin Immunol 1990;90:285-91.
19. Scadding GK, Lund VJ, Jacques LA, Richards DH. A placebo-controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non-allergic perennial rhinitis. Clin Exp Allergy 1995;25:737-43.
20. Waddell AN, Patel SK, Toma AG, Maw AR. Intranasal steroid sprays in the treatment of rhinitis: is one better than another? J Laryngol Otol 2003;117:843-5.
21. Kwaselow A, McLean J, Busse W, Bush R, Reed C, Metzger W, et al. A comparison of intranasal and oral flunisolide in the therapy of allergic rhinitis. Evidence for a topical effect. Allergy 1985;40:363-7.
22. Lindqvist N, Andersson M, Bende M, Loeth S, Pipkorn U. The clinical efficacy of budesonide in hay fever treatment is dependent on topical nasal application. Clin Exp Allergy 1989;19:71-6.
23. Hallworth GW, Padfield JM. A comparison of regional deposition in a model nose of a drug discharged from metered aerosol and metered-pump nasal delivery system. J Allergy Clin Immunol 1986;77:348-53.
24. Mygind N, Vesterhauge S. Aerosol distribution in the nose. Rhinology 1978;16:79-88.
25. Newman SP, Moren F, Clarke SW. Deposition pattern from a nasal pump spray. Rhinology 1987;25:77-82.
26. Batts AH, Marriott C, Martin GP, Bond SW. The effect of some preservatives used in nasal preparations on mucociliary clearance. J Pharm Pharmacol 1989;41:156-9.
27. Berg OH, Lie K, Steinsvag SK. The effect of decongestive nosedrops on human respiratory mucosa in vitro. Laryngoscope 1994;104:1153-8.
28. Naclerio RM, Baroody FM, Bidani N, De Tinoe M, Penney BC. A comparison of nasal clearance after treatment of perennial allergic rhinitis with budesonide and momethasone. Otolaryngol Head Neck Surg 2003;128:220-7.
29. Pedersen B, Larsen BB, Dahl R, Lindqvist N, Mygind N. Powder administration of pure budesonide for the treatment of seasonal allergic rhinitis. Allergy 1991;46:582-7.
30. Pedersen B, Larsen BB, Dahl R, Hedsby L, Mygind N. Budesonide powder administration for the treatment of grass-pollen-induced allergic rhinitis. Allergy 1994;49:855-60.
31. Thorsson L, Newman SP, Weiz A, Trofast E, Móren F. Nasal distribution of budesonide inhaled via a powder inhaler. Rhinology 1993;31:7-10.
32. Agertoft L, Wolthers OD, Fuglsang G, Pedersen S. Nasal powder administration for seasonal rhinitis in children and adolescents. Pediatr Allergy Immunol 1993;4:152-6.
33. Larsen C, Niebuhr Jorgensen M, Tommerup B, Mygind N, Dagrosa EE, Grigoleit HG, et al. Influence of experimental rhinitis on the gonadotropin response to intranasal administration of buserelin. Eur J Clin Pharmacol 1987;33:155-9.
34. Grossman J, Banov C, Bronsky EA, Nathan RA, Pearlman D, Winder JA, et al. Fluticasone propionate aqueous nasal spray is safe and effective for children with seasonal allergic rhinitis. Pediatrics 1993;92:594-9.
35. Pedersen B, Dahl R, Richards DH, Jacques LA, Larsen BB, Pichler W, et al. Once daily fluticasone propionate aqueous nasal spray controls symptoms of most patients with seasonal allergic rhinitis. Allergy 1995;50:794-9.
36. Dolovich J, O'Connor M, Stepner N, Smith A, Sharma RK. Double-blind comparison of intranasal fluticasone propionate, 200 μg, once daily with 200 μg twice daily in the treatment of patients with severe seasonal allergic rhinitis to ragweed. Ann Allergy 1994;72:435-40.
37. Malm L, Wihl JA. Intranasal beclomethasone dipropionate in vasomotor rhinitis. Acta Allerg (Kbh) 1976;31:245-50.
38. Wight RG, Jones AS, Beckingham E, Andersson B, Ek L. A double-blind comparison of intranasal budesonide 400 μg and 800 μg in perennial rhinitis. Clin Otolaryngol 1992;17:354-8.
39. Andersson M, Svensson C, Persson CGA, Akerlund A, Greiff L. Dose-dependent effects of budesonide aqueous nasal spray on symptoms of allergic rhinitis in a daily nasal allergen challenge model. Ann Allergy Asthma Immunol 2000;85:1-5.
40. Ahlstrom-Emanuelsson C, Persson CG, Svensson C, Andersson M, Hosszu Z, Akerlund A, et al. Establishing a model of seasonal allergic rhinitis and demonstrating dose-response to a topical glucocorticosteroid. Ann Allergy Asthma Immunol 2002;89:159-65.
41. Munch E, Gomez G, Harris C, Lack RP, Edwards VA, O'Connor P, et al. An open comparison of dosage frequencies of beclomethasone dipropionate in seasonal allergic rhinitis. Clin Allergy 1981;11:303-9.
42. Nathan RA, Bronsky EA, Fireman P, Grossman J, LaForce CF, Lemanske RF Jr, et al. Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis. Ann Allergy 1991;67:332-8.
43. Banov CH, Woehler TR, LaForce CF, Pearlman DS, Blumenthal DN, Morgan WF, et al. Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitis. Ann Allergy 1994;73:240-6.
44. Rinne J, Simola M, Malmberg H, Haahtela T. Early treatment of perennial rhinitis with budesonide or cetitizine and its effect on long-term outcome. J Allergy Clin Immunol 2002;109:426-32.
45. Toft A, Wihl JA, Toxman J, Mygind N. Double-blind comparison between beclomethasone dipropionate as aerosol and as powder in patients with nasal polyposis. Clin Allergy 1982;12:391-401.
46. Cervin A, Andersson M. Intranasal steroid and septal perforation - an overlooked complication? A description of the course of events and a discussion of the causes. Rhinology 1998;36:128-32.
47. Pipkorn U, Pukander J, Suonpaa J, Makinen J, Lindqvist N. Long-term safety of budesonide nasal aerosol - a 5 year follow up study. Clin Allergy 1988;18:253-9.
48. Passalacqua G, Albano M, Canonica GW, Bachert C, Van Cauwenberge P, Davies RJ, et al. Inhaled and nasal corticosteroids: safety aspects. Allergy 2000;55:16-3.
49. Frauenfelder FT, Myer SM. Posterior subcapsular cataracts associated with nasal or inhalation corticosteroids. Am J Ophthalmol 1990;109:489-90.
50. Simons FE, Persaud MP, Gillespie CA, Cheang M, Shuckett EP. Absence of posterior cataracts in young patients treated with inhaled glucocorticoids. Lancet 1993;342:776-8.
51. Bross-Soriano D, Hanenberg-Milver C, Schimelmitz-Idi J, Arrieta JR, Astorga del Toro R, Bravo-Escobar G. Effects of three nasal topical steroids in the intraocular pressure compartment. Otolaryngol Head Neck Surgery 2004;130:187-91.
52. Suissa S, Baltzan M, Kremer R, Ernst P. Inhaled and nasal corticosteroid use and the risk of fracture. Am J Respir Crit Care Med 2004;169:83-8.
53. Wolthers OD, Pedersen S. Kneemometry assessment of systemic activity of once daily intranasal dry-powder budesonide in children. Allergy 1994;49:96-9.
54. Moller C, Ahlstrom H, Henricson KA, Malmqvist LA, Akerlund A, Hildebrand H. Safety of nasal budesonide in the long-term treatment of children with perennial rhinitis. Clin Exp Allergy 2003;33:816-22.
55. Allen DM, Meltzer EO, Lemansky RF Jr, Philpot EE, Faris MA, Kral KM, et al. No growth suppression in children treated with maximum recommended dose of fluticasone propionate aqueous nasal spray for one year. Allergy Asthma Proc 2002;23:407-13.
56. Boner AL, Sette L. Rhinitis in children: efficacy and safety of a new intranasal corticosteroid. Eur Respir Rev 1994;20:271-3.
57. Skoner D. Update on growth effects of inhaled and intranasal corticosteroids. Curr Opin Allergy Clin Immunol 2002;2:7-10.
58. Greiff L, Andersson M, Svensson C, Linden M, Wollmer P, Brattsand R, et al. Effects of orally inhaled budesonide in seasonal allergic rhinitis. Eur Respir J 1998;11:1268-73.
59. Bousquet J, Chanal I, Alquie MC, Charpin D, Didier A, Germouty J, et al. Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueous nasal spray and disodium cromoglycate aqueous nasal spray. A multicenter, double-blind, double-dummy, parallel-group study. Allergy 1993;48:327-33.
60. Nielsen LP, Mygind N, Dahl R. Intranasal corticosteroids for allergic rhinitis. Superior relief? Drugs 2001;61:1563-79.
61. Weiner JM, Abrahamson MJ, Puy RM. Intranasal corticosteroids versus H1 receptor antagonists in allergic rhinitis: systemic review of randomized controlled trials. Br Med J 1998;317:1624-30.
62. Pullerits T, Praks L, Ristioja V, Lotvall J. Comparison of nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 2002;109:949-55.
63. Wihl JA, Petersen BN, Petersen LN, Gundersen G, Bresson G, Mygind N. Effect of the nonsedative H1-receptor antagonist asthemizole in perennial allergic and nonallergic rhinitis. J Allergy Clin Immunol 1985;75:720-7.
64. Benincasa C, Lloyd RS. Evaluation of fluticasone propionate aqueous nasal spray taken alone and in combination with cetirizine in the prophylactic treatment of seasonal allergic rhinitis. Drug Invest 1994;8:225-33.
65. Pipkorn U, Rundcrantz H, Lindqvist N. Budesonide - a new nasal steroid. Rhinology 1980;18:171-5.
66. Siegel SC, Katz RM, Rachelefsky GS, Geller BD, Montag LL, Brandon ML, et al. Multicentric study of beclomethasone dipropionate nasal aerosol in adults with seasonal allergic rhinitis. J Allergy Clin Immunol 1982;69:345-53.
67. Cockcroft DW, MacCormack DW, Newhouse MT, Hargreave FE. Beclomethasone dipropionate in allergic rhinitis. Can Med Assoc J 1976;115:523-6.
68. Henriksen J, Wenzel A. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing, and asthma. Am Rev Respir Dis 1984;130:1014-8.
69. Reed CE, Marcoux JP, Welsh PW. Effects of topical nasal treatment on asthma. J Allergy Clin Immunol 1988;81:1042-7.
70. Aubier M, Levy J, Clerici C, Neukirch F, Herman D. Different effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis. Am Rev Respir Dis 1992;146:122-6.
71. Corren J, Adinoff AD, Buchmeier AD, Irvin CG. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 1992;90:250-6.
72. Tarlo SM, Cockroft DW, Dolovich J, Hargreave FE. Beclomethasone dipropionate aerosol in perennial rhinitis. J Allergy Clin Immunol 1977;59:232-6.
73. Hansen I, Mygind N. Local effect of intranasal beclomethasone dipropionate aerosol in perennial rhinitis. Acta Allerg (Kbh) 1974;29:281-7.
74. Lindqvist N, Balle VH, Karma P, Karja J, Lindstrom D, Makinen J, et al. Long-term safety and efficacy of budesonide nasal aerosol in perennial rhinitis. A 12-month multicentre study. Allergy 1986;41:179-86.
75. Lofkvist T, Svensson G. Treatment of vasomotor rhinitis with beclomethasone dipropionate. Acta Allerg (Kbh) 1976;31:227-38.
76. Deuschl H, Drettner B. Nasal polyps treated with beclomethasone nasal aerosol. Rhinology 1977;15:17-23.
77. Holopainen E, Grahne B, Malmberg H, Makinen J, Lindqvist N. Budesonide in the treatment of nasal polyposis. Eur J Respir Dis 1982;63(Suppl 122):221-8.
78. Mygind N, Pedersen CB, Prytz S, Sorensen H. Treatment of nasal polyps with intranasal beclomethasone dipropionate aerosol. Clin Allergy 1975;5:159-64.
79. van Camp C, Clement PA. Results of oral steroid treatment in nasal polyposis. Rhinology 1994;32:5-9.
80. Drettner B, Ebbesen A, Nilsson M. Prophylactic treatment with flunisolide after polypectomy. Rhinology 1982;20:149-58.
81. Karlsson G, Rundcrantz H. A randomized trial of intranasal beclomethasone dipropionate after polypectomy. Rhinology 1982;20:144-8.
82. Hallén H, Enerdal J, Graf P. Fluticasone propionate nasal spray is more effective and has a faster onset of action than placebo in treatment of rhinitis medicamentosa. Clin Exp Allergy 1997;27:552-8.
83. Ferguson BJ, Paramaesvaran S, Rubinstein E. A study of the effect of nasal steroid sprays in perennial allergic rhinitis with rhinitis medicamentosa. Otolaryngol Head Neck Surg 2001;125:253-60.
84. Farr BM, Gwaltney JM Jr, Hendley JO, Hayden FG, Naclerio RM, McBride T, et al. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis 1990;162:1173-7.
85. Kaliner MA, Osgutthorpe JD, Fireman P, Anon J, Georgitis J, Davis ML, et al. Sinusitis: bench to bedside. Current findings, future directions. J Allergy Clin Immunol 1997;99(6 Pt 2):S829-48.
86. Qvarnberg Y, Kantola O, Salo J, Toivanen M, Valtonen H, Vuori E. Influence of topical steroid treatment on maxillary sinusitis. Rhinology 1992;30:103-12.
87. Meltzer EO, Busse WW, Druce HM, Metzger WJ, Mitchell DO, Selner J, et al. Assessment of flunisolide nasal spray versus placebo as an adjunct to antibiotic treatment of sinusitis. J Allergy Clin Immunol 1992;89:301.
88. Meltzer EO, Orgel HA, Backhaus JW, Busse WW, Druce HM, Metzger WJ, et al. Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis. J Allergy Clin Immunol 1993;92:812-23.
89. Parikh A, Scadding GK, Baker RC. Topical corticosteroids in chronic rhinosinusitis. Rhinology 2001;39:75-9.
90. Meltzer EO, Charous BL, Busse WW, Zinreich SJ, Lorber RR, Danzig MR. Added releif in the treatment of recurrent sinusitis with adjunctive momethasone furoate nasal spray. J Allergy Clin Immunol 2000;106:630-7.
91. Dolor RJ, Witsell DL, Helkamp AS, Williams JW Jr, Califf RM, Simel DL. Comparison of cefuroxime with and without intranasal fluticasone propionate for the treatment of rhinosinusitis. J Am Med Assoc 2001;286:3097-105.
92. Lund VJ, Black JH, Laszlo Z, Schrewelius C, Akerlund A. Efficacy and tolerability of budesonide aqueous nasal spray in chronic rhinosinusitis patients. Rhinology 2004;42:57-62.
93. Meltzer EO, Orgel HA, Backhaus JW, Busse WW, Druce HM, Metzger WJ, et al. Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis. J Allergy Clin Immunol 1993;92:812-23.
94. Schatz M, Zeiger RS, editors. Asthma and allergy in pregnancy and early infancy. New York: Marcel Dekker, 1993.
95. Gani F, Braida A, Lombardi C, Del Giudice A, Senna GE. Rhinitis in pregnancy. Allerg Immunol (Paris) 2003;35:306-13.
96. Keles N. Treatment of allergic rhinitis during pregnancy. Am J Rhinol 2004;18:23-8.